What's in Vaccine Company, Inc.'s pipeline?

Vaccine Company, Inc. has 2 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Vaccine Company, Inc.'s portfolio?

Top competitors by shared drug class: Arcturus Therapeutics, Inc., Assistance Publique - Hôpitaux de Paris, BioNTech SE, CSPC Megalith Biopharmaceutical Co.,Ltd., CanSino Biologics Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/vaccine-company-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Vaccine Company, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vaccine Company, Inc. pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
COVID-19 mRNA vaccine	COVID-19 mRNA vaccine	marketed	mRNA vaccine	SARS-CoV-2 spike protein (S protein)	Immunology / Infectious Disease

Therapeutic area mix

Immunology / Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Arcturus Therapeutics, Inc. · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
BioNTech SE · 1 shared drug class
CSPC Megalith Biopharmaceutical Co.,Ltd. · 1 shared drug class
CanSino Biologics Inc. · 1 shared drug class
Clover Biopharmaceuticals AUS Pty · 1 shared drug class
Federal University of Espirito Santo · 1 shared drug class
AIM Vaccine Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Vaccine Company, Inc.:

Cite this brief

Drug Landscape (2026). Vaccine Company, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/vaccine-company-inc. Accessed 2026-05-16.